Sex differences in angiotensin-converting enzyme modulation of ang (1-7) levels in normotensive WKY rats

American Journal of Hypertension

Volumn 26, Issue 5, 2013, Pages 591-598

  Bhatia, Kanchan ^a   Zimmerman, Margaret A ^a   Sullivan, Jennifer C ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

blood pressure; gender; hyptertension; kidney; renin angiotensin system; WKY

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN[1-7]; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; MEMBRANE METALLOENDOPEPTIDASE;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; FLUID INTAKE; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TISSUE LEVEL; TREATMENT DURATION; URINE VOLUME; WISTAR KYOTO RAT;

ADMINISTRATION, ORAL; ANGIOTENSIN I; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ENALAPRIL; FEMALE; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; MODELS, ANIMAL; NEPRILYSIN; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, INBRED WKY; SEX CHARACTERISTICS; SEX FACTORS;

EID: 84876550325     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hps088     Document Type: Article

References (39)

1. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007; 292:C82-C97. (Pubitemid 46127306)
2. Brewster UC and Perazella MA. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 2004; 116:263-272. (Pubitemid 38224234)
3. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000; 52:639-672.
4. Dilauro M, Burns KD. Angiotensin-(1-7) and its effects in the kidney. Sci World J 2009; 9:522-535.
5. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counterregulatory actions of angiotensin-(1-7). Hypertension 1997; 30:535-541. (Pubitemid 27444228)
6. Sullivan JC, Bhatia K, Yamamoto T, Elmarakby AA. Angiotensin (1-7) receptor antagonism equalizes angiotensin II-induced hypertension in male and female spontaneously hypertensive rats. Hypertension 2010; 56:658-666.
7. Pendergrass KD, Pirro NT, Westwood BM, Ferrario CM, Brosnihan KB, Chappell MC. Sex differences in circulating and renal angiotensins of hypertensive mRen(2).Lewis but not normotensive Lewis rats. Am J Physiol Heart Circ Physiol 2008; 295:H10-H20.
8. Di Salvo J, Peterson A, Montefusco C, Menta M. Intrarenal conversion of angiotensin I to angiotensin II in the dog. Circ Res 1971; 29:398-406.
9. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal reninangiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59:251-287. (Pubitemid 47481436)
10. Zisman LS, Meixell GE, Bristow MR, Canver CC. Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate. Circulation 2003; 108:1679-1681. (Pubitemid 37243653)
11. Stewart JA Jr, Lazartigues E, Lucchesi PA. The angiotensin converting enzyme 2/Ang-(1-7) axis in the heart: a role for MAS communication Circ Res 2008; 103:1197-1199.
12. Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 2004; 383:45-51. (Pubitemid 39389449)
13. Batlle D, Jose Soler M, Ye M. ACE2 and diabetes: ACE of ACEs Diabetes 2010; 59:2994-2996.
14. Velez JC, Bland AM, Arthur JM, Raymond JR, Janech MG. Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. Am J Physiol Renal Physiol 2007; 293: F398-F407. (Pubitemid 47345041)
15. Liu J, Ji H, Zheng W, Wu X, Zhu JJ, Arnold AP, Sandberg K. Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent. Biol Sex Differ 2010; 1:6.
16. Gupte M, Thatcher SE, Boustany-Kari CM, Shoemaker R, Yiannikouris F, Zhang X, Karounos M, Cassis LA. Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice. Arterioscler Thromb Vasc Biol 2012; 32: 1392-1399.
17. Pollock DM, Rekito A. Hypertensive response to chronic NO synthase inhibition is different in Sprague-Dawley rats from two suppliers. Am J Physiol 1998; 275:R1719-R1723.
18. Santos RA, Krieger EM, Greene LJ. An improved fluorometric assay of rat serum and plasma converting enzyme. Hypertension 1985;7:244-252 (Pubitemid 15093650)
19. Park S, Bivona BJ, Kobori H, Seth DM, Chappell MC, Lazartigues E, Harrison-Bernard LM. Major role for ACE-independent intrarenal ANG II formation in type II diabetes. Am J Physiol Renal Physiol 2010; 298:F37-F48.
20. Florentin D, Sassi A, Roques BP. A highly sensitive fluorometric assay for "enkephalinase," a neutral metalloendopeptidase that releases tyrosine-glycine-glycine from enkephalins. Anal Biochem 1984; 141: 62-69. (Pubitemid 14043261)
21. Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann Tallant E, Smith RD, Chappell MC. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int 2005; 68:2189-2196. (Pubitemid 43117793)
22. Chappell MC, Modrall JG, Diz DI, Ferrario CM. Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7), ACE2 and blood pressure regulation. Contrib Nephrol 2004; 143:77-89.
23. Krege JH, John SW, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, Smithies O. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 1995; 375:146-148.
24. Esther CR, Marino EM, Howard TE, Machaud A, Corvol P, Capecchi MR, Bernstein KE. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest 1997; 99:2375-2385. (Pubitemid 27227714)
25. Sharifi AM, Akbarloo N, Darabi R, Larijani B. Study of correlation between elevation of blood pressure and tissue ACE activity during development of hypertension in 1K1C rats. Vascul Pharmacol 2004; 41:15-20. (Pubitemid 38595541)
26. Kurosawa Y, Katoh M, Doi H, Narita H. Tissue angiotensin-converting enzyme activity plays an important role in pressure overload-induced cardiac fibrosis in rats. J Cardiovasc Pharmacol 2002; 39:600-609. (Pubitemid 34252395)
27. Ceroni A, Moreira ED, Mostarda CT, Silva GJ, Krieger EM, Irigoyen MC. Ace gene dosage influences the development of renovascular hypertension. Clin Exp Pharmacol Physiol 2010; 37:490-495.
28. Sampson AK, Moritz KM, Denton KM. Postnatal ontogeny of angiotensin receptors and ACE2 in male and female rats. Gend Med 2012; 9:21-32.
29. Flores-Munoz M, Work LM, Douglas K, Denby L, Dominiczak AF, Graham D, Nicklin SA. Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor. Hypertension 2012; 59(2):300-307.
30. Oparil S, Tregear GW, Koerner T, Barnes BA, Haber E. Mechanism of pulmonary conversion of angiotensin I to angiotensin II in the dog. Circ Res 1971; 29: 682-690.
31. Johnson H, Kourtis S, Waters J, Drummer OH. Radioimmunoassay for immunoreactive [des-Leu10]-angiotensin I. Peptides (Elmsford). 1989; 10: 489-492.
32. Maris ME, Melchert RB, Joseph J, Kennedy RH. Gender differences in blood pressure and heart rate in spontaneously hypertensive and Wistar-Kyoto rats. Clin Exp Pharmacol Physiol 2005; 32:35-39. (Pubitemid 40314467)
33. Tsuchihashi T, Kagiyama S, Ohya Y, Abe I, Fujishima M. Antihypertensive treatment and the responsiveness to glutamate in ventrolateral medulla. Hypertension 1998; 31:73-76. (Pubitemid 28124695)
34. O'Donnell CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation 1998; 97:1766-1772.
35. Zapater P, Novalbos J, Gallego-Sandin S, Hernandez FT, Abad-Santos F. Gender differences in angiotensin-converting enzyme (ACE) activity and inhibition by enalaprilat in healthy volunteers. J Cardiovasc Pharmacol 2004; 43:737-744. (Pubitemid 38534076)
36. Edeki T, Johnston A, Li Kam Wa E, Turner P. Enalapril pharmacokinetics and ACE inhibition, following single and chronic oral dosing. Int J Clin Pharmacol Ther 1994; 32:142-146. (Pubitemid 24088860)
37. Mathew R, Futterweit S, Valderrama E, Tarectecan AA, Bylander JE, Bond JS, Trachtman H. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis. Am J Physiol Renal Physiol 2005; 289:F911-921. (Pubitemid 41324212)
38. Allred AJ, Diz DI, Ferrario CM, Chappell MC. Pathways for angiotensin-( 1-7) metabolism in pulmonary and renal tissues. Am J Physiol Renal Physiol 2000; 279:F841-F850.
39. Stroupe ST, Craig SS, Gorbea CM, Bond JS. Sex-related differences in meprin-A, a membrane-bound mouse kidney proteinase. Am J Physiol 1991; 261(3 Pt 1):E354-E361.